Mark A. Luscher

1.2k total citations
21 papers, 931 citations indexed

About

Mark A. Luscher is a scholar working on Immunology, Virology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mark A. Luscher has authored 21 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Virology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mark A. Luscher's work include Immune Cell Function and Interaction (14 papers), HIV Research and Treatment (13 papers) and T-cell and B-cell Immunology (10 papers). Mark A. Luscher is often cited by papers focused on Immune Cell Function and Interaction (14 papers), HIV Research and Treatment (13 papers) and T-cell and B-cell Immunology (10 papers). Mark A. Luscher collaborates with scholars based in Canada, United States and Kenya. Mark A. Luscher's co-authors include Brian H. Barber, David B. Williams, Kelly S. MacDonald, Mario Ostrowski, Colin Kovacs, Job J. Bwayo, Francis A. Plummer, Keith R. Fowke, John Freedman and Ephantus Njagi and has published in prestigious journals such as Nature, The Journal of Immunology and Journal of Virology.

In The Last Decade

Mark A. Luscher

21 papers receiving 913 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Luscher Canada 14 679 410 174 160 159 21 931
KATHY E. COBB United States 6 328 0.5× 585 1.4× 239 1.4× 150 0.9× 216 1.4× 7 754
Zachary Caldwell United States 6 347 0.5× 464 1.1× 188 1.1× 200 1.3× 161 1.0× 8 711
J. C. Gluckman France 10 321 0.5× 469 1.1× 190 1.1× 165 1.0× 153 1.0× 21 664
Bruce K. Brown United States 15 557 0.8× 537 1.3× 242 1.4× 309 1.9× 157 1.0× 21 1.1k
Peter Krausa United Kingdom 10 698 1.0× 405 1.0× 168 1.0× 110 0.7× 103 0.6× 12 885
J S McDougal United States 11 488 0.7× 480 1.2× 255 1.5× 79 0.5× 164 1.0× 20 823
Claudia Pastori Italy 16 416 0.6× 602 1.5× 384 2.2× 149 0.9× 177 1.1× 35 912
Jennifer Jones United States 11 388 0.6× 511 1.2× 231 1.3× 196 1.2× 138 0.9× 16 837
Michael Tuen United States 17 469 0.7× 488 1.2× 219 1.3× 163 1.0× 134 0.8× 33 773
Kelly A. Soderberg United States 9 675 1.0× 318 0.8× 130 0.7× 127 0.8× 218 1.4× 12 917

Countries citing papers authored by Mark A. Luscher

Since Specialization
Citations

This map shows the geographic impact of Mark A. Luscher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Luscher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Luscher more than expected).

Fields of papers citing papers by Mark A. Luscher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Luscher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Luscher. The network helps show where Mark A. Luscher may publish in the future.

Co-authorship network of co-authors of Mark A. Luscher

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Luscher. A scholar is included among the top collaborators of Mark A. Luscher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Luscher. Mark A. Luscher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Christie, Natasha, David O. Willer, Michael A. Lobritz, et al.. (2009). Viral fitness implications of variation within an immunodominant CD8+ T-cell epitope of HIV-1. Virology. 388(1). 137–146. 16 indexed citations
2.
Willer, David O., Yongjun Guan, Mark A. Luscher, et al.. (2009). Multi-Low-Dose Mucosal Simian Immunodeficiency Virus SIVmac239 Challenge of Cynomolgus Macaques Immunized with “Hyperattenuated” SIV Constructs. Journal of Virology. 84(5). 2304–2317. 13 indexed citations
3.
Su, Jin, Mark A. Luscher, & Kelly S. MacDonald. (2004). Sequence of � 2 -microglobulin from rhesus macaque ( Macaca mulatta ) includes an allelic variation in the 3'-untranslated region. Immunogenetics. 55(12). 873–877. 4 indexed citations
4.
5.
Clark, David A., Thomas J. Matthews, Kenneth L. Rosenthal, et al.. (2003). Assessing Human Alloimmunization as a Strategy for Inducing HIV Type 1 Neutralizing Anti-HLA Responses. AIDS Research and Human Retroviruses. 19(11). 957–965. 21 indexed citations
6.
Saibil, Samuel D., Toshiaki Ohteki, Forest M. White, et al.. (2003). Weak agonist self‐peptides promote selection and tuning of virus‐specific T cells. European Journal of Immunology. 33(3). 685–696. 15 indexed citations
7.
Luscher, Mark A., Kelly S. MacDonald, Job J. Bwayo, Francis A. Plummer, & Brian H. Barber. (2001). Sequence and peptide-binding motif for a variant of HLA-A*0214 (A*02142) in an HIV-1-resistant individual from the Nairobi Sex Worker cohort. Immunogenetics. 53(1). 10–14. 6 indexed citations
8.
MacDonald, Kelly S., Larissa Matukas, Joanne E. Embree, et al.. (2001). Human leucocyte antigen supertypes and immune susceptibility to HIV-1, implications for vaccine design. Immunology Letters. 79(1-2). 151–157. 25 indexed citations
9.
10.
Luscher, Mark A., John D. Altman, Harriet L. Robinson, et al.. (2001). Simian Immunodeficiency Virus (SIV) Infection of a Rhesus Macaque Induces SIV-Specific CD8+T Cells with a Defect in Effector Function That Is Reversible on Extended Interleukin-2 Incubation. Journal of Virology. 75(6). 3028–3033. 60 indexed citations
11.
Bienzle, Dorothee, Kelly S. MacDonald, Fiona Smaill, et al.. (2000). Factors Contributing to the Lack of Human Immunodeficiency Virus Type 1 (HIV‐1) Transmission in HIV‐1–Discordant Partners. The Journal of Infectious Diseases. 182(1). 123–132. 44 indexed citations
12.
MacDonald, Kelly S., Keith R. Fowke, Joshua Kimani, et al.. (2000). Influence of HLA Supertypes on Susceptibility and Resistance to Human Immunodeficiency Virus Type 1 Infection. The Journal of Infectious Diseases. 181(5). 1581–1589. 199 indexed citations
13.
Luscher, Mark A., Ephantus Njagi, Job J. Bwayo, et al.. (1998). Naturally Occurring IgG Anti-HLA Alloantibody Does Not Correlate with HIV Type 1 Resistance in Nairobi Prostitutes. AIDS Research and Human Retroviruses. 14(2). 109–115. 13 indexed citations
14.
Luscher, Mark A., Joanne E. Embree, Job J. Bwayo, et al.. (1998). Anti-HLA Alloantibody Is Found in Children But Does Not Correlate with a Lack of HIV Type 1 Transmission from Infected Mothers. AIDS Research and Human Retroviruses. 14(2). 99–107. 21 indexed citations
15.
Luscher, Mark A., et al.. (1994). Characteristics of heterologous beta  2-m exchange into H-2Db at the cell surface.. The Journal of Immunology. 153(11). 5068–5081. 11 indexed citations
16.
Luscher, Mark A., et al.. (1991). Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature. 352(6330). 67–70. 294 indexed citations
17.
Carayanniotis, George, et al.. (1991). Adjuvant-independent immunization by immunotargeting antigens to MHc and non-MHc determinants in vivo. Molecular Immunology. 28(3). 261–267. 34 indexed citations
18.
Bunting, John W. & Mark A. Luscher. (1988). Charge transfer complexation of N,N-dimethyl-p-toluidine with nitrogen heteroaromatic cations as a model for association complexes in hydride transfer reactions. Canadian Journal of Chemistry. 66(10). 2532–2539. 2 indexed citations
19.
Bunting, John W. & Mark A. Luscher. (1988). Kinetics of hydride transfer between nitrogen heteroaromatic cations. Canadian Journal of Chemistry. 66(10). 2524–2531. 7 indexed citations
20.
Bunting, John W., Mark A. Luscher, & J. D. Redman. (1987). The oxidation of 4-pyrimidinone and 4-quinazolinone and their N-methyl derivatives by milk xanthine oxidase. Bioorganic Chemistry. 15(2). 125–140. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by KATHY E. COBB Breakdown of academic impact, for papers by Zachary Caldwell Breakdown of academic impact, for papers by J. C. Gluckman Breakdown of academic impact, for papers by Bruce K. Brown Breakdown of academic impact, for papers by Peter Krausa Breakdown of academic impact, for papers by J S McDougal Breakdown of academic impact, for papers by Claudia Pastori Breakdown of academic impact, for papers by Jennifer Jones Breakdown of academic impact, for papers by Michael Tuen Breakdown of academic impact, for papers by Kelly A. Soderberg
Rankless by CCL
2026